A gene signature associated with PTEN activation defines good prognosis intermediate risk prostate cancer cases. (2018)
Attributed to:
The central importance of CXCL8 signaling to inflammatory-based tumour initiation and invasive prostate carcinoma.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/cjp2.94
PubMed Identifier: 29665325
Publication URI: http://europepmc.org/abstract/MED/29665325
Type: Journal Article/Review
Volume: 4
Parent Publication: The journal of pathology. Clinical research
Issue: 2
ISSN: 2056-4538